SPECIALTY DRUG OPTIMIZATION

EVIDENCE BACKED. VALUE BASED. AI DRIVEN.

Specialty Drug Cost
is Out of Control

 

Information and Evidence
is Inaccessible

 

Delivers Optimal Clinical
and Cost Outcomes

GrayMatterAI
leverages Big Data analytics to identify
the most clinically effective specialty medications
at an optimal cost for each patient

We are ushering in a new era of precision medicine –
providing actionable intelligence that enables healthcare providers the ability to
prescribe exactly the right drug, for the right patient, at an optimized value

A Solution for Innovative
Specialty Medicines

GrayMatterAI is giving payers, at-risk providers, physicians,
and biopharmaceutical manufacturers the ability shift from
a volume to a value model through precision analytics;
eliminating inappropriate specialty drug use and lowering
the overall cost burden on the healthcare system